abstract |
Tetrahydroquinoline compounds represented by the following general formula (I), which have a specific and potent AR-binding affinity, exhibit an AG agonistic or antagonistic effect and exert therapeutic effects on diseases mediated by AR (in particular, exerting potent effects on skeleton muscular tissues and bone tissues without showing any excessive effect on the prostate as an AR agonist), or pharmacologically acceptable salts thereof and medicinal compositions containing the same as the active ingredient: (I) |